SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015972
Filing Date
2022-04-26
Accepted
2022-04-26 16:41:38
Documents
9
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20003107x1_def14a.htm DEF 14A 1573609
2 ny20003107x1_barchart01.jpg GRAPHIC 132904
3 ny20003107x1_barchart02.jpg GRAPHIC 195693
4 ny20003107x1_pc1x1.jpg GRAPHIC 710143
5 ny20003107x1_pc2x1.jpg GRAPHIC 683363
6 ny20003107x1_piechart01.jpg GRAPHIC 169351
7 ny20003107x1_piechart02.jpg GRAPHIC 113603
8 ny20003107x1_piechart03.jpg GRAPHIC 144733
9 ny20003107x1_piechart04.jpg GRAPHIC 84941
  Complete submission text file 0001140361-22-015972.txt   4650836
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 22854941
SIC: 2836 Biological Products, (No Diagnostic Substances)